Journal
EMBO MOLECULAR MEDICINE
Volume 3, Issue 11, Pages 667-681Publisher
WILEY
DOI: 10.1002/emmm.201100174
Keywords
glycogen synthase; glycogen; Lafora; malin; neurodegeneration
Categories
Funding
- Ministerio de Ciencia y Innovacion, Spain [BFU2008-00769, BFU2008-03390/BMC, BFU2008-00899]
- Instituto de Salud Carlos III [FI06/00375]
- Torres Quevedo programme [PTQ-08-03-07880]
- Fundacion Marcelino Botin
- CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministerio de Ciencia e Innovacion)
Ask authors/readers for more resources
Lafora disease (LD) is caused by mutations in either the laforin or malin gene. The hallmark of the disease is the accumulation of polyglucosan inclusions called Lafora Bodies (LBs). Malin knockout (KO) mice present polyglucosan accumulations in several brain areas, as do patients of LD. These structures are abundant in the cerebellum and hippocampus. Here, we report a large increase in glycogen synthase (GS) in these mice, in which the enzyme accumulates in LBs. Our study focused on the hippocampus where, under physiological conditions, astrocytes and parvalbumin-positive (PV+) interneurons expressed GS and malin. Although LBs have been described only in neurons, we found this polyglucosan accumulation in the astrocytes of the KO mice. They also had LBs in the soma and some processes of PV+ interneurons. This phenomenon was accompanied by the progressive loss of these neuronal cells and, importantly, neurophysiological alterations potentially related to impairment of hippocampal function. Our results emphasize the relevance of the laforin-malin complex in the control of glycogen metabolism and highlight altered glycogen accumulation as a key contributor to neurodegeneration in LD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available